{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:17:03Z","timestamp":1789064223922,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10620-021-06899-2","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T09:05:09Z","timestamp":1614157509000},"page":"423-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pancreatic Disorders in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"67","author":[{"given":"Marilia L.","family":"Montenegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E.","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Lukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Kr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-6219","authenticated-orcid":false,"given":"Yan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"6899_CR1","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","volume":"65","author":"JM Dahlhamer","year":"2016","unstructured":"Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of inflammatory bowel disease among adults aged >\/=18 years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166\u20131169. https:\/\/doi.org\/10.15585\/mmwr.mm6542a3.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"6899_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","volume":"13","author":"T Greuter","year":"2019","unstructured":"Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease\u2014epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13:307\u2013317. https:\/\/doi.org\/10.1080\/17474124.2019.1574569.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"6899_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-2002-19636","volume":"40","author":"B Bokemeyer","year":"2002","unstructured":"Bokemeyer B. Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn\u2019s disease and ulcerative colitis. Z Gastroenterol. 2002;40:5\u201310. https:\/\/doi.org\/10.1055\/s-2002-19636.","journal-title":"Z Gastroenterol."},{"key":"6899_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/00004836-198812000-00010","volume":"10","author":"S Katz","year":"1988","unstructured":"Katz S, Bank S, Greenberg RE, Lendvai S, Lesser M, Napolitano B. Hyperamylasemia in inflammatory bowel disease. J Clin Gastroenterol. 1988;10:627\u2013630. https:\/\/doi.org\/10.1097\/00004836-198812000-00010.","journal-title":"J Clin Gastroenterol."},{"key":"6899_CR5","first-page":"15","volume":"21","author":"A Tromm","year":"1991","unstructured":"Tromm A, Holtmann B, Huppe D, Kuntz HD, Schwegler U, May B. Hyperamylasemia, hyperlipasemia and acute pancreatitis in chronic inflammatory bowel diseases. Leber Magen Darm. 1991;21:15\u201316 (9-22).","journal-title":"Leber Magen Darm."},{"key":"6899_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF00270584","volume":"73","author":"Y Fujimura","year":"1995","unstructured":"Fujimura Y, Nishishita C, Uchida J, Iida M. Macroamylasemia associated with ulcerative colitis. J Mol Med (Berl). 1995;73:95\u201397. https:\/\/doi.org\/10.1007\/BF00270584.","journal-title":"J Mol Med (Berl)."},{"key":"6899_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4291\/wjgp.v7.i3.276","volume":"7","author":"F Antonini","year":"2016","unstructured":"Antonini F, Pezzilli R, Angelelli L, Macarri G. Pancreatic disorders in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2016;7:276\u2013282. https:\/\/doi.org\/10.4291\/wjgp.v7.i3.276.","journal-title":"World J Gastrointest Pathophysiol."},{"key":"6899_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/MPA.0000000000001650","volume":"49","author":"B Tel","year":"2020","unstructured":"Tel B, Stubnya B, Gede N et al. Inflammatory bowel diseases elevate the risk of developing acute pancreatitis: a meta-analysis. Pancreas. 2020;49:1174\u20131181. https:\/\/doi.org\/10.1097\/MPA.0000000000001650.","journal-title":"Pancreas."},{"key":"6899_CR9","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.3748\/wjg.v23.i19.3505","volume":"23","author":"JW Kim","year":"2017","unstructured":"Kim JW, Hwang SW, Park SH et al. Clinical course of ulcerative colitis patients who develop acute pancreatitis. World J Gastroenterol. 2017;23:3505\u20133512. https:\/\/doi.org\/10.3748\/wjg.v23.i19.3505.","journal-title":"World J Gastroenterol."},{"key":"6899_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.6092\/1590-8577\/2951","volume":"16","author":"S Jasdanwala","year":"2015","unstructured":"Jasdanwala S, Babyatsky M. Crohn\u2019s disease and acute pancreatitis. A review of literature.  JOP. 2015;16:136\u2013142. https:\/\/doi.org\/10.6092\/1590-8577\/2951.","journal-title":"JOP."},{"key":"6899_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/00365529950173096","volume":"34","author":"HH Rasmussen","year":"1999","unstructured":"Rasmussen HH, Fonager K, Sorensen HT, Pedersen L, Dahlerup JF, Steffensen FH. Risk of acute pancreatitis in patients with chronic inflammatory bowel disease. A Danish 16-year nationwide follow-up study. Scand J Gastroenterol. 1999;34:199\u2013201. https:\/\/doi.org\/10.1080\/00365529950173096.","journal-title":"Scand J Gastroenterol."},{"key":"6899_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jgh.13171","volume":"31","author":"YT Chen","year":"2016","unstructured":"Chen YT, Su JS, Tseng CW, Chen CC, Lin CL, Kao CH. Inflammatory bowel disease on the risk of acute pancreatitis: a population-based cohort study. J Gastroenterol Hepatol. 2016;31:782\u2013787. https:\/\/doi.org\/10.1111\/jgh.13171.","journal-title":"J Gastroenterol Hepatol."},{"key":"6899_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000094564","volume":"6","author":"M Barthet","year":"2006","unstructured":"Barthet M, Lesavre N, Desplats S et al. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology. 2006;6:464\u2013471. https:\/\/doi.org\/10.1159\/000094564.","journal-title":"Pancreatology."},{"key":"6899_CR14","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14244.2","author":"A Mandalia","year":"2018","unstructured":"Mandalia A, Wamsteker EJ, DiMagno MJ. Recent advances in understanding and managing acute pancreatitis. F1000Res. 2018. https:\/\/doi.org\/10.12688\/f1000research.14244.2.","journal-title":"F1000Res."},{"key":"6899_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12794","volume":"40","author":"E Gizard","year":"2014","unstructured":"Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40:3\u201315. https:\/\/doi.org\/10.1111\/apt.12794.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR16","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.21537","volume":"45","author":"F Parente","year":"2007","unstructured":"Parente F, Pastore L, Bargiggia S et al. Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study. Hepatology. 2007;45:1267\u20131274. https:\/\/doi.org\/10.1002\/hep.21537.","journal-title":"Hepatology."},{"key":"6899_CR17","doi-asserted-by":"publisher","first-page":"e7653","DOI":"10.1097\/MD.0000000000007653","volume":"96","author":"YH Jeong","year":"2017","unstructured":"Jeong YH, Kim KO, Lee HC et al. Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population. Medicine (Baltimore). 2017;96:e7653. https:\/\/doi.org\/10.1097\/MD.0000000000007653.","journal-title":"Medicine (Baltimore)."},{"key":"6899_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3748\/wjg.v12.i1.70","volume":"12","author":"A Lapidus","year":"2006","unstructured":"Lapidus A, Akerlund JE, Einarsson C. Gallbladder bile composition in patients with Crohn \u2019s disease. World J Gastroenterol. 2006;12:70\u201374. https:\/\/doi.org\/10.3748\/wjg.v12.i1.70.","journal-title":"World J Gastroenterol."},{"key":"6899_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ibd.3780040204","volume":"4","author":"A Lapidus","year":"1998","unstructured":"Lapidus A, Einarsson C. Bile composition in patients with ileal resection due to Crohn\u2019s disease. Inflamm Bowel Dis. 1998;4:89\u201394. https:\/\/doi.org\/10.1002\/ibd.3780040204.","journal-title":"Inflamm Bowel Dis."},{"key":"6899_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/bf01347906","volume":"31","author":"P Rutgeerts","year":"1986","unstructured":"Rutgeerts P, Ghoos Y, Vantrappen G, Fevery J. Biliary lipid composition in patients with nonoperated Crohn\u2019s disease. Dig Dis Sci. 1986;31:27\u201332. https:\/\/doi.org\/10.1007\/bf01347906.","journal-title":"Dig Dis Sci."},{"key":"6899_CR21","doi-asserted-by":"publisher","first-page":"e0185193","DOI":"10.1371\/journal.pone.0185193","volume":"12","author":"S Fagagnini","year":"2017","unstructured":"Fagagnini S, Heinrich H, Rossel JB et al. Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases. PLoS ONE. 2017;12:e0185193. https:\/\/doi.org\/10.1371\/journal.pone.0185193.","journal-title":"PLoS ONE."},{"key":"6899_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/ajg.2016.564","volume":"112","author":"A Mark-Christensen","year":"2017","unstructured":"Mark-Christensen A, Brandsborg S, Laurberg S et al. Increased risk of gallstone disease following colectomy for ulcerative colitis. Am J Gastroenterol. 2017;112:473\u2013478. https:\/\/doi.org\/10.1038\/ajg.2016.564.","journal-title":"Am J Gastroenterol."},{"key":"6899_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bpg.2010.02.002","volume":"24","author":"CJ Nitsche","year":"2010","unstructured":"Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143\u2013155. https:\/\/doi.org\/10.1016\/j.bpg.2010.02.002.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"6899_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cgh.2006.11.023","volume":"5","author":"N Badalov","year":"2007","unstructured":"Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648\u2013661. https:\/\/doi.org\/10.1016\/j.cgh.2006.11.023 (quiz 4).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6899_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MCG.0b013e3181cadbe1","volume":"44","author":"CS Pitchumoni","year":"2010","unstructured":"Pitchumoni CS, Rubin A, Das K. Pancreatitis in inflammatory bowel diseases. J Clin Gastroenterol. 2010;44:246\u2013253. https:\/\/doi.org\/10.1097\/MCG.0b013e3181cadbe1.","journal-title":"J Clin Gastroenterol."},{"key":"6899_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ecco-jcc\/jjv188","volume":"10","author":"N Teich","year":"2016","unstructured":"Teich N, Mohl W, Bokemeyer B et al. Azathioprine-induced acute pancreatitis in patients with inflammatory bowel diseases\u2014a prospective study on incidence and severity. J Crohns Colitis. 2016;10:61\u201368. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv188.","journal-title":"J Crohns Colitis."},{"key":"6899_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2036.2008.03746.x","volume":"28","author":"F Bermejo","year":"2008","unstructured":"Bermejo F, Lopez-Sanroman A, Taxonera C et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther. 2008;28:623\u2013628. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03746.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.3093","volume":"46","author":"GA Heap","year":"2014","unstructured":"Heap GA, Weedon MN, Bewshea CM et al. HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nat Genet. 2014;46:1131\u20131134. https:\/\/doi.org\/10.1038\/ng.3093.","journal-title":"Nat Genet."},{"key":"6899_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2036.2004.02197.x","volume":"20","author":"RK Weersma","year":"2004","unstructured":"Weersma RK, Peters FT, Oostenbrug LE et al. Increased incidence of azathioprine-induced pancreatitis in Crohn\u2019s disease compared with other diseases. Aliment Pharmacol Ther. 2004;20:843\u2013850. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02197.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ecco-jcc\/jjv153","volume":"10","author":"LR Ramos","year":"2016","unstructured":"Ramos LR, Sachar DB, DiMaio CJ, Colombel JF, Torres J. Inflammatory bowel disease and pancreatitis: a review. J Crohns Colitis. 2016;10:95\u2013104. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv153.","journal-title":"J Crohns Colitis."},{"key":"6899_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: gastrointestinal and endocrinologic side effects. J Am Acad Dermatol. 2017;76:11\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239.","journal-title":"J Am Acad Dermatol."},{"key":"6899_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1001\/jamainternmed.2013.2737","volume":"173","author":"O Sadr-Azodi","year":"2013","unstructured":"Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013;173:444\u2013449. https:\/\/doi.org\/10.1001\/jamainternmed.2013.2737.","journal-title":"JAMA Intern Med."},{"key":"6899_CR33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.016","author":"A Meczker","year":"2020","unstructured":"Meczker A, Hanak L, Parniczky A et al. Analysis of 1060 cases of drug-induced acute pancreatitis. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.016.","journal-title":"Gastroenterology."},{"key":"6899_CR34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJM197002122820710","volume":"282","author":"MB Block","year":"1970","unstructured":"Block MB, Genant HK, Kirsner JB. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med. 1970;282:380\u2013382. https:\/\/doi.org\/10.1056\/NEJM197002122820710.","journal-title":"N Engl J Med."},{"key":"6899_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MPA.0000000000001297","volume":"48","author":"A Meczker","year":"2019","unstructured":"Meczker A, Miko A, Gede N et al. Retrospective matched-cohort analysis of acute pancreatitis induced by 5-aminosalicylic acid-derived drugs. Pancreas. 2019;48:488\u2013495. https:\/\/doi.org\/10.1097\/MPA.0000000000001297.","journal-title":"Pancreas."},{"key":"6899_CR36","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/apt.14688","volume":"47","author":"P Sehgal","year":"2018","unstructured":"Sehgal P, Colombel JF, Aboubakr A, Narula N. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Ther. 2018;47:1597\u20131609. https:\/\/doi.org\/10.1111\/apt.14688.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/gut.51.4.536","volume":"51","author":"RA Ransford","year":"2002","unstructured":"Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002;51:536\u2013539. https:\/\/doi.org\/10.1136\/gut.51.4.536.","journal-title":"Gut."},{"key":"6899_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1590\/s0102-86502012000700010","volume":"27","author":"AM Coelho","year":"2012","unstructured":"Coelho AM, Kunitake TA, Machado MC et al. Is there a therapeutic window for pentoxifylline after the onset of acute pancreatitis? Acta Cir Bras. 2012;27:487\u2013493. https:\/\/doi.org\/10.1590\/s0102-86502012000700010.","journal-title":"Acta Cir Bras."},{"key":"6899_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/00006676-200401000-00020","volume":"28","author":"N Oruc","year":"2004","unstructured":"Oruc N, Ozutemiz AO, Yukselen V et al. Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas. 2004;28:e1-8. https:\/\/doi.org\/10.1097\/00006676-200401000-00020.","journal-title":"Pancreas."},{"key":"6899_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1053\/j.gastro.2015.04.019","volume":"149","author":"SS Vege","year":"2015","unstructured":"Vege SS, Atwal T, Bi Y, Chari ST, Clemens MA, Enders FT. Pentoxifylline treatment in severe acute pancreatitis: a pilot, double-blind, placebo-controlled. Randomized Trial Gastroenterol 2015;149:318\u201320.e3. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.019.","journal-title":"Randomized Trial Gastroenterol"},{"key":"6899_CR41","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.14309\/crj.2017.103","volume":"4","author":"ME Werlang","year":"2017","unstructured":"Werlang ME, Lewis MD, Bartel MJ. Tumor necrosis factor alpha inhibitor-induced acute pancreatitis. ACG Case Rep J. 2017;4:e103. https:\/\/doi.org\/10.14309\/crj.2017.103.","journal-title":"ACG Case Rep J."},{"key":"6899_CR42","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/1060028014540869","volume":"48","author":"DJ Stobaugh","year":"2014","unstructured":"Stobaugh DJ, Deepak P. Effect of tumor necrosis factor-alpha inhibitors on drug-induced pancreatitis in inflammatory bowel disease. Ann Pharmacother. 2014;48:1282\u20131287. https:\/\/doi.org\/10.1177\/1060028014540869.","journal-title":"Ann Pharmacother."},{"key":"6899_CR43","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/ibd\/izy067","volume":"24","author":"O Ledder","year":"2018","unstructured":"Ledder O, Turner D. Antibiotics in IBD: still a role in the biological era? Inflamm Bowel Dis. 2018;24:1676\u20131688. https:\/\/doi.org\/10.1093\/ibd\/izy067.","journal-title":"Inflamm Bowel Dis."},{"key":"6899_CR44","doi-asserted-by":"publisher","first-page":"4840539","DOI":"10.1155\/2019\/4840539","volume":"2019","author":"I Youssef","year":"2019","unstructured":"Youssef I, Saeed N, El Abdallah M, Huevelhorst K, Zakharia K. Metronidazole-induced pancreatitis: is there underrecognition? a case report and systematic review of the literature. Case Rep Gastrointest Med. 2019;2019:4840539. https:\/\/doi.org\/10.1155\/2019\/4840539.","journal-title":"Case Rep Gastrointest Med."},{"key":"6899_CR45","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2147\/CLEP.S159702","volume":"10","author":"A Barbulescu","year":"2018","unstructured":"Barbulescu A, Oskarsson V, Lindblad M, Ljung R, Brooke HL. Oral metronidazole use and risk of acute pancreatitis: a population-based case-control study. Clin Epidemiol. 2018;10:1573\u20131581. https:\/\/doi.org\/10.2147\/CLEP.S159702.","journal-title":"Clin Epidemiol."},{"key":"6899_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2036.2005.02344.x","volume":"21","author":"M Norgaard","year":"2005","unstructured":"Norgaard M, Ratanajamit C, Jacobsen J, Skriver MV, Pedersen L, Sorensen HT. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2005;21:415\u2013420. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02344.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR47","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.26355\/eurrev_201910_19179","volume":"23","author":"D Pagliari","year":"2019","unstructured":"Pagliari D, Saviano A, Brizi MG et al. Cannabis-induced acute pancreatitis: a case report with comprehensive literature review. Eur Rev Med Pharmacol Sci. 2019;23:8625\u20138629. https:\/\/doi.org\/10.26355\/eurrev_201910_19179.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"6899_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.dld.2017.08.040","volume":"49","author":"A Culetto","year":"2017","unstructured":"Culetto A, Bournet B, Buscail L. Clinical profile of cannabis-associated acute pancreatitis. Dig Liver Dis. 2017;49:1284\u20131285. https:\/\/doi.org\/10.1016\/j.dld.2017.08.040.","journal-title":"Dig Liver Dis."},{"key":"6899_CR49","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s10620-018-5169-2","volume":"63","author":"CR Simons-Linares","year":"2018","unstructured":"Simons-Linares CR, Barkin JA, Wang Y et al. Is there an effect of cannabis consumption on acute pancreatitis? Dig Dis Sci. 2018;63:2786\u20132791. https:\/\/doi.org\/10.1007\/s10620-018-5169-2.","journal-title":"Dig Dis Sci."},{"key":"6899_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpeds.2018.03.041","volume":"199","author":"EJ Hoffenberg","year":"2018","unstructured":"Hoffenberg EJ, McWilliams SK, Mikulich-Gilbertson SK et al. Marijuana use by adolescents and young adults with inflammatory bowel disease. J Pediatr. 2018;199:99\u2013105. https:\/\/doi.org\/10.1016\/j.jpeds.2018.03.041.","journal-title":"J Pediatr."},{"key":"6899_CR51","doi-asserted-by":"publisher","first-page":"e4878","DOI":"10.7759\/cureus.4878","volume":"11","author":"S Ghazaleh","year":"2019","unstructured":"Ghazaleh S, Alqahtani A, Nehme C, Abugharbyeh A, Said Ahmed TS. A rare case of cannabis-induced acute pancreatitis. Cureus. 2019;11:e4878. https:\/\/doi.org\/10.7759\/cureus.4878.","journal-title":"Cureus."},{"key":"6899_CR52","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.12998\/wjcc.v7.i9.1006","volume":"7","author":"AT Chatila","year":"2019","unstructured":"Chatila AT, Bilal M, Guturu P. Evaluation and management of acute pancreatitis. World J Clin Cases. 2019;7:1006\u20131020. https:\/\/doi.org\/10.12998\/wjcc.v7.i9.1006.","journal-title":"World J Clin Cases."},{"key":"6899_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.alcohol.2009.10.019","volume":"44","author":"GR Swanson","year":"2010","unstructured":"Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 2010;44:223\u2013228. https:\/\/doi.org\/10.1016\/j.alcohol.2009.10.019.","journal-title":"Alcohol."},{"key":"6899_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.20524\/aog.2018.0302","volume":"31","author":"G Mantzouranis","year":"2018","unstructured":"Mantzouranis G, Fafliora E, Saridi M et al. Alcohol and narcotics use in inflammatory bowel disease. Ann Gastroenterol. 2018;31:649\u2013658. https:\/\/doi.org\/10.20524\/aog.2018.0302.","journal-title":"Ann Gastroenterol."},{"key":"6899_CR55","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.dld.2018.06.024","volume":"50","author":"A Belle","year":"2018","unstructured":"Belle A, Laurent V, Pouillon L et al. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease. Dig Liver Dis. 2018;50:1012\u20131018. https:\/\/doi.org\/10.1016\/j.dld.2018.06.024.","journal-title":"Dig Liver Dis."},{"key":"6899_CR56","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/liv.13548","volume":"38","author":"JO Sorensen","year":"2018","unstructured":"Sorensen JO, Nielsen OH, Andersson M et al. Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977\u20132011. Liver Int. 2018;38:532\u2013541. https:\/\/doi.org\/10.1111\/liv.13548.","journal-title":"Liver Int."},{"key":"6899_CR57","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00261-019-02275-x","volume":"45","author":"A Khandelwal","year":"2020","unstructured":"Khandelwal A, Inoue D, Takahashi N. Autoimmune pancreatitis: an update. Abdom Radiol (NY). 2020;45:1359\u20131370. https:\/\/doi.org\/10.1007\/s00261-019-02275-x.","journal-title":"Abdom Radiol (NY)."},{"key":"6899_CR58","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.3748\/wjg.v20.i44.16559","volume":"20","author":"H Matsubayashi","year":"2014","unstructured":"Matsubayashi H, Kakushima N, Takizawa K et al. Diagnosis of autoimmune pancreatitis. World J Gastroenterol. 2014;20:16559\u201316569. https:\/\/doi.org\/10.3748\/wjg.v20.i44.16559.","journal-title":"World J Gastroenterol."},{"key":"6899_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8070916","author":"T Iida","year":"2019","unstructured":"Iida T, Wagatsuma K, Hirayama D, Yokoyama Y, Nakase H. The etiology of pancreatic manifestations in patients with inflammatory bowel disease. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8070916.","journal-title":"J Clin Med."},{"key":"6899_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0036-1584318","volume":"36","author":"S Kawa","year":"2016","unstructured":"Kawa S. Current concepts and diagnosis of IgG4-related pancreatitis (Type 1 AIP). Semin Liver Dis. 2016;36:257\u2013273. https:\/\/doi.org\/10.1055\/s-0036-1584318.","journal-title":"Semin Liver Dis."},{"key":"6899_CR61","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.gastro.2018.06.082","volume":"155","author":"K Miyabe","year":"2018","unstructured":"Miyabe K, Zen Y, Cornell LD et al. Gastrointestinal and extra-intestinal manifestations of IgG4-related disease. Gastroenterology. 2018;155:990-1003.e1. https:\/\/doi.org\/10.1053\/j.gastro.2018.06.082.","journal-title":"Gastroenterology."},{"key":"6899_CR62","first-page":"4537","volume":"11","author":"X Chen","year":"2018","unstructured":"Chen X, Sun W, Lin R, Huang Z, Chen W. IgG4+ plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4. Int J Clin Exp Pathol. 2018;11:4537\u20134544","journal-title":"Int J Clin Exp Pathol."},{"key":"6899_CR63","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1038\/s41598-018-28397-8","volume":"8","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhu M, Luo C et al. High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease. Sci Rep. 2018;8:10018. https:\/\/doi.org\/10.1038\/s41598-018-28397-8.","journal-title":"Sci Rep."},{"key":"6899_CR64","first-page":"216","volume":"79","author":"HD Simsek","year":"2016","unstructured":"Simsek HD, Basyigit S, Aktas B et al. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining. Acta Gastroenterol Belg. 2016;79:216\u2013221","journal-title":"Acta Gastroenterol Belg."},{"key":"6899_CR65","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1038\/ajg.2009.327","volume":"104","author":"L Frulloni","year":"2009","unstructured":"Frulloni L, Scattolini C, Falconi M et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288\u20132294. https:\/\/doi.org\/10.1038\/ajg.2009.327.","journal-title":"Am J Gastroenterol."},{"key":"6899_CR66","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.dld.2016.05.008","volume":"48","author":"L Roque Ramos","year":"2016","unstructured":"Roque Ramos L, DiMaio CJ, Sachar DB, Atreja A, Colombel JF, Torres J. Autoimmune pancreatitis and inflammatory bowel disease: case series and review of the literature. Dig Liver Dis. 2016;48:893\u2013898. https:\/\/doi.org\/10.1016\/j.dld.2016.05.008.","journal-title":"Dig Liver Dis."},{"key":"6899_CR67","doi-asserted-by":"publisher","first-page":"743","DOI":"10.14740\/jocmr3561w","volume":"10","author":"FS Fousekis","year":"2018","unstructured":"Fousekis FS, Theopistos VI, Katsanos KH, Christodoulou DK. Pancreatic involvement in inflammatory bowel disease: a review. J Clin Med Res. 2018;10:743\u2013751. https:\/\/doi.org\/10.14740\/jocmr3561w.","journal-title":"J Clin Med Res."},{"key":"6899_CR68","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","volume":"4","author":"ST Chari","year":"2006","unstructured":"Chari ST, Smyrk TC, Levy MJ et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010\u20131016. https:\/\/doi.org\/10.1016\/j.cgh.2006.05.017 (quiz 934).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6899_CR69","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa T, Chari ST, Frulloni L et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352\u2013358. https:\/\/doi.org\/10.1097\/MPA.0b013e3182142fd2.","journal-title":"Pancreas."},{"key":"6899_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4291\/wjgp.v5.i2.71","volume":"5","author":"DA O'Reilly","year":"2014","unstructured":"O\u2019Reilly DA, Malde DJ, Duncan T, Rao M, Filobbos R. Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol. 2014;5:71\u201381. https:\/\/doi.org\/10.4291\/wjgp.v5.i2.71.","journal-title":"World J Gastrointest Pathophysiol."},{"key":"6899_CR71","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mric.2018.03.008","volume":"26","author":"N Hafezi-Nejad","year":"2018","unstructured":"Hafezi-Nejad N, Singh VK, Fung C, Takahashi N, Zaheer A. MR imaging of autoimmune pancreatitis. Magn Reson Imaging Clin N Am. 2018;26:463\u2013478. https:\/\/doi.org\/10.1016\/j.mric.2018.03.008.","journal-title":"Magn Reson Imaging Clin N Am."},{"key":"6899_CR72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5009\/gnl18429","volume":"13","author":"D Oh","year":"2019","unstructured":"Oh D, Song TJ, Moon SH et al. Type 2 autoimmune pancreatitis (idiopathic duct-centric pancreatitis) highlighting patients presenting as clinical acute pancreatitis: a single-center experience. Gut Liver. 2019;13:461\u2013470. https:\/\/doi.org\/10.5009\/gnl18429.","journal-title":"Gut Liver."},{"key":"6899_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/003655202753416876","volume":"37","author":"J Jahnsen","year":"2002","unstructured":"Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192\u2013199. https:\/\/doi.org\/10.1080\/003655202753416876.","journal-title":"Scand J Gastroenterol."},{"key":"6899_CR74","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/MCG.0000000000001033","volume":"53","author":"A Shah","year":"2019","unstructured":"Shah A, Walker M, Burger D et al. Link between celiac disease and inflammatory bowel disease. J Clin Gastroenterol. 2019;53:514\u2013522. https:\/\/doi.org\/10.1097\/MCG.0000000000001033.","journal-title":"J Clin Gastroenterol."},{"key":"6899_CR75","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cgh.2012.06.023","volume":"10","author":"O Sadr-Azodi","year":"2012","unstructured":"Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF. Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol. 2012;10:1136-1142.e3. https:\/\/doi.org\/10.1016\/j.cgh.2012.06.023.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6899_CR76","doi-asserted-by":"publisher","first-page":"S488","DOI":"10.14309\/00000434-201710001-00865","volume":"112","author":"T Sawas","year":"2017","unstructured":"Sawas T, Asfari MM, Cho WK. Endoscopic retrograde cholangiopancreatography is safe in inflammatory bowel disease: 864. Am J Gastroenterol. 2017;112:S488\u2013S489","journal-title":"Am J Gastroenterol."},{"key":"6899_CR77","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/s1072-7515(00)00701-8","volume":"191","author":"SH Burkey","year":"2000","unstructured":"Burkey SH, Valentine RJ, Jackson MR, Modrall JG, Clagett GP. Acute pancreatitis after abdominal vascular surgery. J Am Coll Surg. 2000;191:373\u2013380. https:\/\/doi.org\/10.1016\/s1072-7515(00)00701-8.","journal-title":"J Am Coll Surg."},{"key":"6899_CR78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s0002-9610(70)80100-3","volume":"120","author":"MT White","year":"1970","unstructured":"White MT, Morgan A, Hopton D. Postoperative pancreatitis. A study of seventy cases. Am J Surg. 1970;120:132\u2013137. https:\/\/doi.org\/10.1016\/s0002-9610(70)80100-3.","journal-title":"Am J Surg."},{"key":"6899_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/mpa.0b013e318149f5bf","volume":"36","author":"AZ Al-Bahrani","year":"2008","unstructured":"Al-Bahrani AZ, Abid GH, Holt A et al. Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis. Pancreas. 2008;36:39\u201343. https:\/\/doi.org\/10.1097\/mpa.0b013e318149f5bf.","journal-title":"Pancreas."},{"key":"6899_CR80","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/0300060517747163","volume":"46","author":"WC Liao","year":"2018","unstructured":"Liao WC, Chen YH, Li HY et al. Diaphragmatic dysfunction in sepsis due to severe acute pancreatitis complicated by intra-abdominal hypertension. J Int Med Res. 2018;46:1349\u20131357. https:\/\/doi.org\/10.1177\/0300060517747163.","journal-title":"J Int Med Res."},{"key":"6899_CR81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00006676-199611000-00005","volume":"13","author":"DM Parenti","year":"1996","unstructured":"Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas. 1996;13:356\u2013371. https:\/\/doi.org\/10.1097\/00006676-199611000-00005.","journal-title":"Pancreas."},{"key":"6899_CR82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ncpgasthep1004","volume":"5","author":"PM Irving","year":"2008","unstructured":"Irving PM, Gibson PR. Infections and IBD. Nat Clin Pract Gastroenterol Hepatol. 2008;5:18\u201327. https:\/\/doi.org\/10.1038\/ncpgasthep1004.","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"key":"6899_CR83","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/17474124.2018.1530983","volume":"12","author":"ZA Borman","year":"2018","unstructured":"Borman ZA, Cote-Daigneault J, Colombel JF. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update. Expert Rev Gastroenterol Hepatol. 2018;12:1101\u20131108. https:\/\/doi.org\/10.1080\/17474124.2018.1530983.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"6899_CR84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5217\/ir.2017.15.1.97","volume":"15","author":"P Harsh","year":"2017","unstructured":"Harsh P, Gupta V, Kedia S et al. Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India. Intest Res. 2017;15:97\u2013102. https:\/\/doi.org\/10.5217\/ir.2017.15.1.97.","journal-title":"Intest Res."},{"key":"6899_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.14740\/gr858w","volume":"10","author":"P Rawla","year":"2017","unstructured":"Rawla P, Bandaru SS, Vellipuram AR. Review of infectious etiology of acute pancreatitis. Gastroenterol Res. 2017;10:153\u2013158. https:\/\/doi.org\/10.14740\/gr858w.","journal-title":"Gastroenterol Res."},{"key":"6899_CR86","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.3346\/jkms.2018.33.e292","volume":"33","author":"J Kang","year":"2018","unstructured":"Kang J, Jeong DH, Han M et al. Incidence of active tuberculosis within one year after tumor necrosis factor inhibitor treatment according to latent tuberculosis infection status in patients with inflammatory bowel disease. J Korean Med Sci. 2018;33:e292. https:\/\/doi.org\/10.3346\/jkms.2018.33.e292.","journal-title":"J Korean Med Sci."},{"key":"6899_CR87","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/ibd\/izy045","volume":"24","author":"J Johnson","year":"2018","unstructured":"Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K. CMV disease in IBD: comparison of diagnostic tests and correlation with disease outcome. Inflamm Bowel Dis. 2018;24:1539\u20131546. https:\/\/doi.org\/10.1093\/ibd\/izy045.","journal-title":"Inflamm Bowel Dis."},{"key":"6899_CR88","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pan.2020.03.001","volume":"20","author":"H Yasuda","year":"2020","unstructured":"Yasuda H, Horibe M, Sanui M et al. Etiology and mortality in severe acute pancreatitis: a multicenter study in Japan. Pancreatology. 2020;20:307\u2013317. https:\/\/doi.org\/10.1016\/j.pan.2020.03.001.","journal-title":"Pancreatology."},{"key":"6899_CR89","doi-asserted-by":"publisher","unstructured":"PanWessex Study G, Wessex Surgical Trainee Research C, Mirnezami A, Knight B, Moran B, Noble F et al. Population-based observational study of acute pancreatitis in southern England. Ann R Coll Surg Engl. 2019;101:487\u201394. doi:https:\/\/doi.org\/10.1308\/rcsann.2019.0055.","DOI":"10.1308\/rcsann.2019.0055"},{"key":"6899_CR90","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/MPA.0000000000001102","volume":"47","author":"DX Jin","year":"2018","unstructured":"Jin DX, Lacson R, Cochon LR et al. A clinical model for the early diagnosis of acute pancreatitis in the emergency department. Pancreas. 2018;47:871\u2013879. https:\/\/doi.org\/10.1097\/MPA.0000000000001102.","journal-title":"Pancreas."},{"key":"6899_CR91","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C et al. Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102\u2013111. https:\/\/doi.org\/10.1136\/gutjnl-2012-302779.","journal-title":"Gut."},{"key":"6899_CR92","first-page":"105","volume":"23","author":"JK Triantafillidis","year":"2010","unstructured":"Triantafillidis JK, Merikas E. Pancreatic involvement in patients with inflammatory bowel disease. Ann Gastroenterol. 2010;23:105\u2013112","journal-title":"Ann Gastroenterol."},{"key":"6899_CR93","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/MIB.0000000000000739","volume":"22","author":"A Alexoff","year":"2016","unstructured":"Alexoff A, Roginsky G, Zhou Y, Kalenda M, Minuskin K, Ehrenpreis ED. Inpatient costs for patients with inflammatory bowel disease and acute pancreatitis. Inflamm Bowel Dis. 2016;22:1095\u20131100. https:\/\/doi.org\/10.1097\/MIB.0000000000000739.","journal-title":"Inflamm Bowel Dis."},{"key":"6899_CR94","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10620-017-4518-x","volume":"62","author":"ML Ramsey","year":"2017","unstructured":"Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62:1745\u20131750. https:\/\/doi.org\/10.1007\/s10620-017-4518-x.","journal-title":"Dig Dis Sci."},{"key":"6899_CR95","first-page":"347","volume":"50","author":"WP Ball","year":"1950","unstructured":"Ball WP, Baggenstoss AH, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol (Chic). 1950;50:347\u2013358","journal-title":"Arch Pathol (Chic)."},{"key":"6899_CR96","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0016-5085(56)80104-2","volume":"30","author":"LE Chapin","year":"1956","unstructured":"Chapin LE, Scudamore HH, Baggenstoss AH, Bargen JA. Regional enteritis: associated visceral changes. Gastroenterology. 1956;30:404\u2013415","journal-title":"Gastroenterology."},{"key":"6899_CR97","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/03007995.2017.1300143","volume":"33","author":"YL Chen","year":"2017","unstructured":"Chen YL, Hsu CW, Cheng CC et al. Increased subsequent risk of inflammatory bowel disease association in patients with chronic pancreatitis: a nationwide population-based cohort study. Curr Med Res Opin. 2017;33:1077\u20131082. https:\/\/doi.org\/10.1080\/03007995.2017.1300143.","journal-title":"Curr Med Res Opin."},{"key":"6899_CR98","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/j.1572-0241.1999.01287.x","volume":"94","author":"M Barthet","year":"1999","unstructured":"Barthet M, Hastier P, Bernard JP et al. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol. 1999;94:2141\u20132148. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01287.x.","journal-title":"Am J Gastroenterol."},{"key":"6899_CR99","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10620-007-9852-y","volume":"53","author":"G Maconi","year":"2008","unstructured":"Maconi G, Dominici R, Molteni M et al. Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1. Dig Dis Sci. 2008;53:262\u2013270. https:\/\/doi.org\/10.1007\/s10620-007-9852-y.","journal-title":"Dig Dis Sci."},{"key":"6899_CR100","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","volume":"11","author":"YS Jung","year":"2017","unstructured":"Jung YS, Han M, Park S, Kim WH, Cheon JH. Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study. J Crohns Colitis. 2017;11:954\u2013962. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx040.","journal-title":"J Crohns Colitis."},{"key":"6899_CR101","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/apt.15785","volume":"52","author":"AH Everhov","year":"2020","unstructured":"Everhov AH, Erichsen R, Sachs MC et al. Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969\u20132017. Aliment Pharmacol Ther. 2020;52:143\u2013154. https:\/\/doi.org\/10.1111\/apt.15785.","journal-title":"Aliment Pharmacol Ther."},{"key":"6899_CR102","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.049","author":"PJ Trivedi","year":"2020","unstructured":"Trivedi PJ, Crothers H, Mytton J et al. Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel diseases, based on sex, race, and age. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.049.","journal-title":"Gastroenterology."},{"key":"6899_CR103","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pan.2014.04.029","volume":"14","author":"T Ikeura","year":"2014","unstructured":"Ikeura T, Miyoshi H, Uchida K et al. Relationship between autoimmune pancreatitis and pancreatic cancer: a single-center experience. Pancreatology. 2014;14:373\u2013379. https:\/\/doi.org\/10.1016\/j.pan.2014.04.029.","journal-title":"Pancreatology."},{"key":"6899_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15163","author":"T Ishikawa","year":"2020","unstructured":"Ishikawa T, Kawashima H, Ohno E et al. Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients. J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1111\/jgh.15163.","journal-title":"J Gastroenterol Hepatol."},{"key":"6899_CR105","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/01.mib.0000186485.30623.ad","volume":"11","author":"P Moolsintong","year":"2005","unstructured":"Moolsintong P, Loftus EV Jr, Chari ST, Egan LJ, Tremaine WJ, Sandborn WJ. Acute pancreatitis in patients with Crohn\u2019s disease: clinical features and outcomes. Inflamm Bowel Dis. 2005;11:1080\u20131084. https:\/\/doi.org\/10.1097\/01.mib.0000186485.30623.ad.","journal-title":"Inflamm Bowel Dis."},{"key":"6899_CR106","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/j.1572-0241.2007.01279.x","volume":"102","author":"A Andriulli","year":"2007","unstructured":"Andriulli A, Loperfido S, Napolitano G et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781\u20131788. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01279.x.","journal-title":"Am J Gastroenterol."},{"key":"6899_CR107","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.3748\/wjg.v16.i19.2331","volume":"16","author":"M Kopacova","year":"2010","unstructured":"Kopacova M, Tacheci I, Rejchrt S, Bartova J, Bures J. Double balloon enteroscopy and acute pancreatitis. World J Gastroenterol. 2010;16:2331\u20132340. https:\/\/doi.org\/10.3748\/wjg.v16.i19.2331.","journal-title":"World J Gastroenterol."},{"key":"6899_CR108","first-page":"2134","volume":"90","author":"MR Fortson","year":"1995","unstructured":"Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90:2134\u20132139","journal-title":"Am J Gastroenterol."},{"key":"6899_CR109","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1210\/jc.2008-1965","volume":"94","author":"TK Khoo","year":"2009","unstructured":"Khoo TK, Vege SS, Abu-Lebdeh HS, Ryu E, Nadeem S, Wermers RA. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab. 2009;94:2115\u20132118. https:\/\/doi.org\/10.1210\/jc.2008-1965.","journal-title":"J Clin Endocrinol Metab."},{"key":"6899_CR110","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ajg.2011.63","volume":"106","author":"AJ Yarur","year":"2011","unstructured":"Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741\u2013747. https:\/\/doi.org\/10.1038\/ajg.2011.63.","journal-title":"Am J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06899-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T15:34:28Z","timestamp":1646062468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["6899"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06899-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical standards"}},{"value":"No conflicts of interest or financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}